The medication is technically only FDA approved to treat Type 2 diabetes, but its so effective at reducing body weight that healthcare providers often prescribe it off-label as a weight loss medication
Any other glucagon-like-peptide-1 receptor agonist must not be used in adjunct with Semaglutide
Read more: Ozempic, the miracle drug, and the harmful idea of a future without fat As a family physician with a PhD in nutrition, I translate the latest nutrition science into dietary recommendations for my patients
Common Side Effects: Nausea (most common, especially during titration), vomiting, diarrhea, constipation, abdominal pain, dyspepsia
Semaglutide (Wegovy) is part of a group of medicines called GLP-1 receptor agonists, commonly used as weight loss injections
A proper skin assessment is more appropriate than assuming that stimulating pigmentation will address the underlying concern